Chief Executive Officer at Atommap.
Earliest Form D on file: Mar 2026
Protein motion simulation for small-molecule drug design
Biotech, New York NY
Signed as Chief Executive Officer
$31.1M
sold of $59.6M offered
Form D
LinkedIn
Keith Loebner
Director
Browse by sector
Browse by state